Articles in Editor’s Picks
There’s been a lot of media attention lately placed on the safety, or non-safety, of ingesting foods and beverages packaged in polycarbonate containers made from the chemical bisphenol A (BPA). BPA is most often …
The findings of a study conducted by the University of Minnesota Children’s Hospital, Minneapolis, leads to the conclusion that just growing up as a male increases the risk of heart disease by the time the …
A unanimous vote, 36-0, in the Massachusetts Senate passes legislation pertaining to healthcare reforms within the state. The bill is the first of its kind in the nation although Minnesota and Vermont both have …
Nalgene Outdoor Products, the Rochester, New York, company that manufactures the popular water bottles and baby bottles characterized by hard, clear plastic that is almost impossible to break has announced that they will no longer …
Disease Some people diagnosed with Crohn disease turn to alternative remedies for relief. Many turn to omega-3 free fatty acids, known for their ability to relieve the symptoms of other inflammatory disorders, such as rheumatoid …
The US Food and Drug Administration (FDA) has just released some important statistics that reveal the number of heparin-related deaths before and after the recent recall of heparin and heparin-related products manufactured and/or distributed by …
A couple of intriguing theories have emerged following a study into the cost-effectiveness of giving free samples of prescription medications to patients. It seems the free samples are closely linked to some pretty steep …
Although more common in little boys, ADHD does affect little girls, too, and new research is showing that it affects girls differently than it does boys, especially once the girls reach adolescence.
According to the findings of a study presented today at the 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, hosted by the American Heart Association, many teenagers invest as much time watching television and …
Researchers at Massachusetts General Hospital report good news for the drug, Femara (letrozole), used to prevent the recurrence of some forms of breast cancer, even when started long after the initial course of treatment has …










